The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.

BACKGROUND:Interferon-beta (IFN-beta) is a commonly used treatment for multiple sclerosis (MS). Current guidelines recommend cessation of treatment during pregnancy, however the results of past studies on the safety of prenatal exposure to IFN-beta have been conflicting. A large scale study of a pop...

Full description

Bibliographic Details
Main Authors: Sarah Burkill, Pia Vattulainen, Yvonne Geissbuehler, Meritxell Sabido Espin, Catrinel Popescu, Kiliana Suzart-Woischnik, Jan Hillert, Miia Artama, Auli Verkkoniemi-Ahola, Kjell-Morten Myhr, Sven Cnattingius, Pasi Korhonen, Scott Montgomery, Shahram Bahmanyar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0227120